Atosiban Impurity 16 represents a related peptide species formed during atosiban manufacture or storage. Variations in residue composition or linkage pattern alter retention time and conformational profile. Researchers employ it to refine analytical separation and impurity thresholds. Applications include process-development insight, stability-indicating method design, and structural-variant analysis.
CAT No: R2738
Synonyms/Alias:(S)-N-((S)-5-amino-1-((2-amino-2-oxoethyl)amino)-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-13-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide;Val3-Atosiban
Atosiban impurity 16 is a specialized carbohydrate compound that plays a significant role in analytical research and pharmaceutical development. Carefully characterized for its structural properties, Atosiban impurity 16 is utilized primarily as a reference standard in laboratory settings, where its presence and behavior can help elucidate the properties and stability of related substances. Its unique molecular arrangement enables researchers to distinguish between the main active pharmaceutical ingredient and its associated impurities, providing essential insights into process optimization and quality control. The compound's consistency and reliability make it a valuable asset in various scientific investigations, especially those focused on the detailed profiling of peptide-based therapeutics.
Pharmaceutical Analysis: Atosiban impurity 16 is extensively employed in pharmaceutical analysis to support the identification and quantification of impurities within drug formulations. By serving as a comparative standard during chromatographic and spectrometric evaluations, it allows analysts to accurately detect and measure trace levels of related substances in complex mixtures. This process is crucial for maintaining the integrity of the main product and ensuring that manufacturing methods yield consistent and high-quality results. The use of this impurity standard facilitates the development of robust analytical methods, enabling laboratories to monitor the presence of undesired byproducts throughout various stages of production.
Method Validation: In the context of method validation, the carbohydrate compound is indispensable for assessing the specificity, accuracy, and precision of analytical procedures. Laboratories incorporate Atosiban impurity 16 into their validation protocols to confirm that their methods can reliably distinguish between the principal compound and its structurally similar impurities. This practice not only strengthens the credibility of analytical results but also supports the ongoing improvement of testing methodologies. By providing a well-defined reference point, the impurity assists in the calibration of instruments and the fine-tuning of detection parameters, ultimately enhancing the reliability of routine quality assessments.
Stability Studies: The inclusion of Atosiban impurity 16 in stability studies provides critical information regarding the degradation pathways of pharmaceutical products. Researchers use the compound to simulate real-world storage and handling conditions, tracking the formation and evolution of impurities over time. The data generated from these studies inform decisions about optimal storage environments and packaging materials, reducing the risk of product degradation and ensuring a longer shelf life. Through its role in stability testing, the impurity contributes to a deeper understanding of how external factors influence the integrity of peptide-based drugs.
Process Development: During process development, Atosiban impurity 16 is leveraged to evaluate and refine synthetic routes for peptide manufacturing. By monitoring the levels of this and other related impurities, chemists can identify critical control points within the production workflow. The insights gained from these studies lead to the optimization of reaction conditions, purification steps, and overall process efficiency. As a result, manufacturers are better equipped to minimize the formation of undesired byproducts, improve yield, and streamline the scale-up of pharmaceutical synthesis.
Research and Development: In research and development settings, the impurity serves as a tool for exploring new analytical technologies and innovative approaches to impurity profiling. Scientists may use Atosiban impurity 16 to challenge existing detection platforms or to develop novel assays tailored to the unique characteristics of peptide impurities. Its application in R&D initiatives accelerates the advancement of analytical science and fosters the creation of next-generation solutions for impurity monitoring. By supporting these forward-looking projects, the compound plays a pivotal role in driving progress within the fields of pharmaceutical analysis and peptide research.
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More